Jeremy Young, MD
Hospitalist · Winston Salem, NCNPI 1730385501
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 389 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 17.5% — the pattern of someone who eats at a lot of different presentations. Among hospitalist clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 389 payments — averaging $17.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$1K
- AbbVie$1K
- Novartis$698
- AstraZeneca$653
- Boehringer Ingelheim$604
- Merck$555
- plus $2K from 20 others
What the payments were for
- Food & beverage$6,941100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 71 | $1,215 |
| AbbVie(2 entities) | 50 | $1,105 |
| Novartis | 45 | $698 |
| AstraZeneca(2 entities) | 43 | $653 |
| Boehringer Ingelheim | 32 | $604 |
| Merck | 31 | $555 |
| Johnson & Johnson | 33 | $461 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 17 | $392 |
| Gilead | 9 | $209 |
| E.r. Squibb & Sons, L.L.C. | 14 | $191 |
| Boston Scientific | 6 | $133 |
| Otsuka America Pharmaceutical, Inc. | 6 | $104 |
| SK Life Science, Inc. | 3 | $100 |
| Paratek Pharmaceuticals, Inc. | 5 | $96 |
| Novo Nordisk | 5 | $78 |
| Sunovion Pharmaceuticals Inc. | 4 | $64 |
| Lundbeck LLC | 2 | $47 |
| Smith+Nephew | 2 | $39 |
| Philips North America LLC | 2 | $34 |
| Electromed, Inc. | 2 | $30 |
| Cvrx, Inc. | 2 | $30 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $24 |
| Abbott | 1 | $23 |
| Melinta Therapeutics, LLC | 1 | $21 |
| Bayer | 1 | $21 |
| Shire North American Group Inc | 1 | $14 |
How this compares
$6,941 in reported general payments places this provider in the 95th percentile of 879 hospitalist providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 25 | $13,960 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 20 | $469 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $416 |
| Oxybutynin Chloride | 11 | $220 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 11 | $205 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 12 | $185 |
| Ondansetron Hcl | 31 | $180 |
| Furosemide | 45 | $155 |
| Hydralazine Hcl | 15 | $133 |
| Metoprolol Succinate | 23 | $100 |
| Cefdinir | 12 | $82 |
| Doxycycline Monohydrate | 13 | $73 |
| Carvedilol | 11 | $36 |
| Pantoprazole Sodium | 16 | $35 |
| Prednisone | 14 | $25 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $1,215 | $13,96025 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 879 hospitalist providers in North Carolina.
Other hospitalist in Winston Salem
- Mahesh ChandrasekharWinston Salem$86K
- Thomas WolffWinston Salem$8K
- Martin AgbemabieseWinston Salem$8K
- Christopher FortWinston Salem$7K
- Brendan McQuellonWinston Salem$7K
- Kale RothWinston Salem$7K
- Christopher PhillipsWinston Salem$7K
- Nortei DowuonaWinston Salem$6K
- Vidhya ChandramohanWinston Salem$6K
- Jennifer HausmanWinston Salem$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.